Myasthenia gravis: Diagnostic journey and therapeutic outcomes in patients followed at a Brazilian public tertiary center — A retrospective cohort study
Diego Silva Figueiredo, Alberto Rolim Muro Martinez, Anamarli Nucci, Marcondes Cavalcante França Junior · 2026
Read Myasthenia gravis: Diagnostic journey and therapeutic outcomes in patients followed at a Brazilian public tertiary center — A retrospective cohort study by Diego Silva Figueiredo, Alberto Rolim Muro Martinez, Anamarli Nucci, Marcondes Cavalcante França Junior (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13411926.txt.
Description
Diego Silva Figueiredo and co-authors review, in a 2026 retrospective study, how myasthenia gravis is diagnosed and treated at a Brazilian public referral hospital. The autoimmune disease weakens muscles by disrupting signals at the nerve-muscle junction, and published data from poorer health systems remain scarce. Records and questionnaires covered 150 adults seen during 2024 and 2025.
Women made up about two thirds of the group, and most patients had the generalized form. The middle wait for a diagnosis was eleven months, with nearly half waiting a year or longer. About 14 percent had disease that resisted standard drugs, and crises were most common in that group. The authors press for faster recognition and better steroid-sparing care.
Catalog record
| CREATOR | Diego Silva Figueiredo, Alberto Rolim Muro Martinez, Anamarli Nucci, Marcondes Cavalcante França Junior |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |